AngioDynamics, Inc. (ANGO) is a publicly traded Healthcare sector company. As of May 21, 2026, ANGO trades at $11.81 with a market cap of $457.40M and a P/E ratio of -15.46. ANGO moved +3.15% today. Year to date, ANGO is -10.73%; over the trailing twelve months it is +24.19%. Its 52-week range spans $5.83 to $13.99. Analyst consensus is strong buy with an average price target of $16.00. Rallies surfaces ANGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AngioDynamics Down 5.8% with RSI at 9.16 as EPS Estimates Rise 24.1%: AngioDynamics shares have dropped 5.8% over the past four weeks, with its RSI plunging to 9.16 well below the 30 oversold threshold. Meanwhile, sell-side analysts have raised AngioDynamics’ consensus EPS estimate 24.1% in 30 days, earning it a Zacks Rank #2 Buy.
| Metric | Value |
|---|---|
| Price | $11.81 |
| Market Cap | $457.40M |
| P/E Ratio | -15.46 |
| EPS | $-0.76 |
| Dividend Yield | 0.00% |
| 52-Week High | $13.99 |
| 52-Week Low | $5.83 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $313.73M |
| Net Income | $-31.39M |
| Gross Margin | 54.30% |
3 analysts cover ANGO: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.00.